EPO and COVID-19: Due to the similarity of hypoxia-induced symptoms in COVID-19 and high-altitude disorders such as acute mountain sickness and high-altitude pulmonary edema, some initial studies had also suggested using drugs like nifedipine, phosphodiesterase inhibitors, erythropoietin, and dexamethasone (Soliz et al., 2020; Solaimanzadeh, 2019).